Insulin Dose Adjustment Recommendation
Increase Lantus to 15-20 units daily, tighten the ICR to 1:10, and adjust the ISF to 1:20 for this hospitalized patient with neutropenic fever showing persistent hyperglycemia despite current therapy.
Rationale for Basal Insulin Adjustment
Your patient's glucose pattern reveals inadequate basal insulin coverage. The fasting glucose of 215 mg/dL and evening glucose of 233 mg/dL despite minimal carbohydrate intake earlier in the day indicate basal insulin insufficiency. For hospitalized patients with type 2 diabetes, the recommended starting dose is 0.2-0.5 units/kg/day total daily dose (TDD), with approximately 50% as basal insulin 1.
At 104 kg, this patient's calculated range would be:
- Conservative approach (0.2 units/kg): ~21 units TDD = 10-11 units basal
- Standard approach (0.4 units/kg): ~42 units TDD = 21 units basal
- Current dose: Only 5 units basal is grossly inadequate
Given the acute illness (neutropenic fever increases insulin resistance), recent Mounjaro use (which may have been masking insulin requirements), and persistent hyperglycemia, I recommend increasing Lantus to 15-20 units daily 2. The 2025 ADA guidelines support increasing basal insulin by 2 units every 3 days until fasting glucose targets are met, but in the hospital setting with close monitoring, larger adjustments are appropriate 2.
Prandial Insulin Ratio Adjustments
Insulin-to-Carbohydrate Ratio (ICR)
The current 1:15 ratio is too lenient. After consuming 98g carbohydrates at dinner (requiring ~6.5 units by current ratio), the glucose rose from 152 to 233 mg/dL (an 81 mg/dL increase), demonstrating inadequate prandial coverage.
Tighten the ICR to 1:10 (1 unit per 10g carbohydrate). This aligns with the standard formula of 500/TDD 3. If we estimate a more appropriate TDD of 40-50 units for this patient, the calculation yields: 500/45 = 1:11, which rounds to 1:10 3, 4.
Insulin Sensitivity Factor (ISF)
The current ISF of 1:25 is also insufficient. Using the 1800 rule for rapid-acting insulin: 1800/TDD 3. With an estimated TDD of 40-50 units: 1800/45 = 1:40 would be the calculated ISF. However, given acute illness and insulin resistance from infection, start with a more conservative 1:20-25 and titrate based on response 3.
Hospital-Specific Considerations
Critical context: This patient has neutropenic fever, which significantly increases insulin resistance 5. The Endocrine Society guidelines specifically recommend using the "insulin-resistant" column for correction doses in patients with acute illness 1.
For hospitalized patients, basal-bolus insulin therapy with correction doses is strongly recommended over sliding scale insulin alone 1, 6. The correction insulin scale should use 4-6 units for glucose 141-180 mg/dL in insulin-resistant patients 1.
Monitoring and Titration Plan
- Increase Lantus to 15-20 units given at the same time daily 7
- Change ICR to 1:10 for all meals
- Adjust ISF to 1:20 for correction doses
- Use correction insulin before each meal using the "insulin-resistant" column (4-6 units for glucose 141-180 mg/dL) 1
- Reassess daily and increase basal by 2-4 units every 1-2 days if fasting glucose remains >140 mg/dL 2
Important Caveats
Watch for overbasalization: If basal dose exceeds 0.5 units/kg/day (~50 units for this patient) without achieving targets, consider that prandial insulin may need further adjustment rather than continuing to increase basal 8, 9. Signs include high bedtime-to-morning glucose differential or postprandial excursions 8.
Hypoglycemia risk: While this patient has normal renal function now, acute illness can affect insulin clearance. If hypoglycemia occurs, reduce the corresponding insulin component by 10-20% 2. However, given current hyperglycemia, this is not an immediate concern.
Mounjaro effect: The GLP-1/GIP agonist was last taken 12 days ago. Its effect has likely waned (half-life ~5 days), but this may have been suppressing the patient's true insulin requirements 2.